Machine-Learning Guided Medication Selection Frameworks Incorporating Socioeconomic Influence Factors

Abstract

The integration of machine learning (ML) into clinical decision-making has significantly transformed predictive modeling in healthcare, particularly in areas such as mortality prediction, hospitalization risk assessment, and resource optimization. However, despite substantial advancements in algorithmic performance, most existing models remain predominantly biomedical in focus, often neglecting the socioeconomic determinants that critically shape patient outcomes and medication response variability. This paper proposes a conceptual and analytical framework for machine-learning guided medication selection systems that incorporate socioeconomic influence factors (SIFs) to improve precision, fairness, and clinical applicability.

Drawing on prior research in predictive healthcare modeling, including ICU mortality prediction, heart failure risk stratification, and federated learning-based hospitalization forecasting (Rahman et al., 2022; Li et al., 2021; Soffer et al., 2021), this study synthesizes methodological insights into a unified medication selection framework. It emphasizes the role of heterogeneous data integration, including electronic health records (EHRs), laboratory indicators, and socioeconomic attributes such as income level, education, geographic accessibility, and healthcare affordability.

A central contribution of this work is the alignment of clinical machine learning systems with socio-technical considerations, reinforcing the argument that algorithmic fairness and contextual awareness are essential for safe deployment in real-world healthcare environments. The paper further analyzes how advanced machine learning architectures such as gradient boosting systems, federated learning frameworks, and hybrid deep learning models can be adapted for medication recommendation tasks.

Additionally, the study critically examines limitations in current ML-based healthcare systems, including dataset bias, lack of interpretability, and weak generalizability across populations. It argues that incorporating socioeconomic variables can significantly improve model robustness and equity in medication selection, especially in resource-constrained settings.

The framework is contextualized with reference to AI-driven healthcare optimization literature, including socioeconomic-aware pharmaceutical design strategies (Nidiganti, 2024), which highlight the importance of integrating social determinants of health into predictive modeling pipelines. Overall, this study contributes a structured pathway toward next-generation intelligent clinical decision-support systems that are both predictive and socially adaptive.